Gene-expression profiles in hereditary breast cancer.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  New England Journal of Medicine

• Publication date

  2001-02-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1056/NEJM200102223440801PMID 11207349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inherited BRCA2 mutation associated with high grade breast cancer

  2004cited by this paper
• Expert Commentary.

  2002cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Molecular classification of cutaneous malignant melanoma by gene expression profiling

  2000cited by this paper
• Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

  2000cited by this paper
• Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

  2000cited by this paper
• Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.

  2000cited by this paper
• Tissue Classification with Gene Expression Profiles

  2000cited by this paper
• Insights into the functions of BRCA1 and BRCA2.

  2000cited by this paper
• Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation.

  2000cited by this paper
• The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.

  2000cited by this paper
• Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics

  1999cited by this paper
• Connective Tissue Growth Factor Induces Apoptosis in Human Breast Cancer Cell Line MCF-7*

  1999cited by this paper
• TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal.

  1999cited by this paper
• Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays.

  1998cited by this paper
• Enhanced high density oligonucleotide array-based sequence analysis using modified nucleoside triphosphates.

  1998cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper
• Population-based study of risk of breast cancer in carriers of BRCA2 mutation.

  1998cited by this paper
• Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

  1998cited by this paper
• Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes

  1998cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

  1998cited by this paper
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases

  1997cited by this paper
• Brca2 hereditary breast cancer pathophenotype

  1997cited by this paper
• Ratio-based decisions and the quantitative analysis of cDNA microarray images.

  1997cited by this paper
• Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.

  1997cited by this paper
• Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families

  1997cited by this paper
• Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2

  1997cited by this paper
• Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

  1997cited by this paper
• Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

  1997cited by this paper
• Population genetics of BRCA1 and BRCA2.

  1997cited by this paper
• Tumour biological features of BRCA1-induced breast and ovarian cancer.

  1997cited by this paper
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.

  1997cited by this paper
• Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.

  1997cited by this paper
• Biochemistry and genetics of eukaryotic mismatch repair.

  1996cited by this paper
• Use of a cDNA microarray to analyse gene expression patterns in human cancer

  1996cited by this paper
• Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

  1996cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Unusual case of Smith-Lemli-Opitz syndrome "type II".

  1995cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• Tightening the clinical trial.

  1993cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper

• Oncologic Outcomes by Pathogenic BRCA Mutation Status in Young Luminal Breast Cancer: A Propensity-Matched Cohort.

  2026cites this paper
• Semi-Quantitative Evaluation of BRCA1 Protein in Breast Tumors Using Anti-BRCA1 Antibodies: Clinical Implications.

  2026cites this paper
• Identification of metabolism-associated molecular classification for effect and prognosis in lung adenocarcinoma based on multidatabases including the cancer genome atlas and gene expression omnibus

  2025cites this paper
• Random irregular histograms

  2025cites this paper
• Comments on the paper “Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple‐negative breast cancer” by Y. Chen et al.

  2025cites this paper
• Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer

  2025cites this paper
• Structure preserving t-SNE of matrix framed data

  2025cites this paper
• Quantum-Inspired Optimization with Explainable AI for Gene Expression-based Hepatocellular Carcinoma Detection

  2025cites this paper
• Effect of pesticides on breast cancer tumor

  2025cites this paper
• Comparative Genomic and Microenvironmental Profiles of Hereditary and Sporadic TNBC in Colombian Women

  2025cites this paper
• Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis

  2024cites this paper
• Homologous recombination deficiency (HRD) diagnostics: underlying mechanisms and new perspectives

  2024cites this paper
• Pesticide exposure and increased breast cancer risk in women population studies.

  2024cites this paper
• Emerging methods and techniques for cancer biomarker discovery.

  2024cites this paper
• Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers

  2024cites this paper
• Breast cancer prognosis through the use of multi-modal classifiers: current state of the art and the way forward.

  2024cites this paper
• Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond

  2024cites this paper
• Integrated High-throughput Transcriptomic Data Identifies Survivin as a Potential Breast Cancer Therapeutic Biomarker.

  2023cites this paper
• Benefits and Harms of Mammography Screening in 75 + Women to Inform Shared Decision-making: a Simulation Modeling Study

  2023cites this paper
• Exceedance control of the false discovery proportion via high precision inversion method of Berk-Jones statistics

  2023cites this paper
• Thresholding Gini variable importance with a single-trained random forest: An empirical Bayes approach

  2023cites this paper
• Biological and clinical significance of the glypican-3 gene in human lung adenocarcinoma: An in silico analysis

  2023cites this paper
• CBDT-Oglyc: Prediction of O-glycosylation sites using ChiMIC-based balanced decision table and feature selection

  2023cites this paper
• Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status

  2023cites this paper
• Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

  2022cites this paper
• Scoping review: obese elderly women with breast cancer and physical activity/exercise

  2022cites this paper
• Nondestructive protein sampling with electroporation facilitates profiling of spatial differential protein expression in breast tumors in vivo

  2022cites this paper
• Multiple testing in genome-wide association studies via hierarchical hidden Markov models

  2022cites this paper
• The extended concurrent genes signature for disease-free survival in breast cancer.

  2022cites this paper
• Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor–Positive Breast Cancer

  2022cites this paper
• Epigenetic Factors as Etiological Agents, Diagnostic Markers, and Therapeutic Targets for Luminal Breast Cancer

  2022cites this paper
• Metabolomics of Breast Cancer: A Review

  2022cites this paper
• New Approach about the Signaling Crosstalk between IQGAPs/NF- κB/IL-8 and PDCD5/p53/TRAIL Pathways that Modulate Malignant Transformation in Hepatocellular Carcinoma

  2022cites this paper
• Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer

  2022cites this paper
• Multiple comparison procedures for discrete uniform and homogeneous tests

  2021cites this paper
• Racial Disparities in Adverse Cardiovascular Outcomes After a Myocardial Infarction in Young or Middle‐Aged Patients

  2021cites this paper
• Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter

  2021cites this paper
• Gene Expression-Assisted Cancer Prediction Techniques

  2021cites this paper
• Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers

  2021cites this paper
• Feature Selection for Colon Cancer Detection Using K-Means Clustering and Modified Harmony Search Algorithm

  2021cites this paper
• General ways to improve false coverage rate-adjusted selective confidence intervals

  2021cites this paper
• Increased gene expression variability in BRCA1-associated and basal-like breast tumours

  2021cites this paper
• Genomic Diversity in Sporadic Breast Cancer in a Latin American Population

  2020cites this paper
• Joint Bayesian Variable Selection and Graph Estimation for Non-linear SVM with Application to Genomics Data

  2020cites this paper
• Genome-Wide Gene Expression Analyses of BRCA1- and BRCA2-Associated Breast and Ovarian Tumours

  2020influential citation
• Weighted step-down confidence procedures with applications to gene expression data

  2020influential citation
• Cancer Classification and Gene Selection with Machine Learning Method

  2020cites this paper
• Validity of whole genomes sequencing results in neoplasms in precision medicine

  2020cites this paper
• Gene Expression Classification of Lung Adenocarcinoma into Molecular Subtypes

  2020cites this paper
• Uncovering Potential Roles of Differentially Expressed Genes, Upstream Regulators, and Canonical Pathways in Endometriosis Using an In Silico Genomics Approach

  2020cites this paper
• LESSONS LEARNED FROM UNDERSTANDING CHEMOTHERAPY RESISTANCE IN EPITHELIAL TUBO-OVARIAN CARCINOMA FROM BRCA1 AND BRCA2 MUTATION CARRIERS.

  2020cites this paper
• Trade-Off between Anytime- and Sometime-Valid Methods for Merging P-Values

  2020cites this paper
• Advances in quantitative immunohistochemistry and their contribution to breast cancer

  2020cites this paper
• Primal-Dual Stochastic Subgradient Method For Log-Determinant Optimization

  2020cites this paper
• MicroRNA-638 induces apoptosis and autophagy in human liver cancer cells by targeting enhancer of zeste homolog 2 (EZH2).

  2020cites this paper
• The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer

  2020cites this paper
• Order-Preserving Biclustering Based on FCA and Pattern Structures

  2020cites this paper
• Establishment and Characterization of a Brca1−/−, p53−/− Mouse Mammary Tumor Cell Line

  2020cites this paper
• The significance of gene mutations across eight major cancer types.

  2019cites this paper
• A Review of Microarray Datasets: Where to Find Them and Specific Characteristics.

  2019cites this paper
• Identification of driver genes and somatic mutations in cell‐free DNA of patients with pulmonary lymphangioleiomyomatosis

  2019cites this paper
• Constitutional Mosaic Epimutations - a hidden cause of cancer?

  2019cites this paper
• C-HMOSHSSA: Gene selection for cancer classification using multi-objective meta-heuristic and machine learning methods

  2019cites this paper
• Testing equality of a large number of densities under mixing conditions

  2019cites this paper
• PDCD5 inhibits osteosarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with good prognosis.

  2019cites this paper
• Modulation of the Epigenome (Methylome) to Improve Chemotherapeutic Efficacy

  2019cites this paper
• A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables

  2019cites this paper
• Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures

  2019cites this paper
• True and false discoveries with e-values

  2019cites this paper
• Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC

  2019cites this paper
• Association of Activity Altering Genotypes - Tyr113His and His139Arg in Microsomal Epoxide Hydrolase Enzyme with Esophageal Squamous Cell Carcinoma

  2019cites this paper
• The role of the p-value in the multitesting problem

  2019influential citation
• Gene Subset Selection Approaches Based on Linear Separability

  2019cites this paper
• Heterogeneity of breast cancer: the importance of interaction between different tumor cell populations.

  2019cites this paper
• Molecular harvesting with electroporation for tissue profiling

  2019cites this paper
• Clinicopathological Significance of Decreased Expression of the Tumor Inhibitor Gene PDCD5 in Osteoclastoma

  2019cites this paper
• The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine

  2019cites this paper
• Overview of the genetic basis toward early detection of breast cancer

  2019cites this paper
• Genetic Epidemiology of Breast Cancer in Latin America

  2019cites this paper
• A two-sample test for the equality of univariate marginal distributions for high-dimensional data

  2019cites this paper
• Biomarkers for Homologous Recombination Deficiency in Cancer

  2018cites this paper
• A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?

  2018cites this paper
• Comprehensive Proteomic Profiling–derived Immunohistochemistry-based Prediction Models for BRCA1 and BRCA2 Germline Mutation-related Breast Carcinomas

  2018cites this paper
• BRCA mutations and reproduction.

  2018cites this paper
• Classification of State Trajectories in Gene Regulatory Networks

  2018cites this paper
• A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation.

  2018cites this paper
• Myriads: P‐value‐based multiple testing correction

  2018cites this paper
• Distributions associated with simultaneous multiple hypothesis testing

  2018cites this paper
• Programmed cell death 5 suppresses AKT-mediated cytoprotection of endothelium

  2018cites this paper
• Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15

  2018cites this paper
• Evolving Genomics of Pulmonary Fibrosis

  2018cites this paper
• Genetic variation in the DNA repair pathway as a potential determinant of response to platinum‐based chemotherapy in breast cancer

  2018cites this paper
• Minimizing inequality in access to precision medicine in breast cancer by real‐time population‐based molecular analysis in the SCAN‐B initiative

  2018cites this paper
• Mechanics of the Cell Nucleus.

  2018cites this paper
• Identification of tissue-specific tumor biomarker using different optimization algorithms

  2018cites this paper
• Cancer Genomics and Evolution

  2017cites this paper
• Reparameterization of PAM50 expression identifies novel breast tumor dimensions and leads to discovery of a breast cancer susceptibility locus at 12q15

  2017cites this paper
• Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer

  2017cites this paper
• Gene selection for microarray cancer classification using a new evolutionary method employing artificial intelligence concepts.

  2017cites this paper
• Gene Expression data

  2017cites this paper